Edwards Lifesciences Corporation (BMV:EW)
1,372.00
0.00 (0.00%)
At close: Oct 10, 2025
Edwards Lifesciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 3,273 | 3,045 | 1,132 | 769 | 862.8 | 1,183 | Upgrade |
Short-Term Investments | 789.4 | 930.7 | 500.5 | 446.3 | 604 | 219.4 | Upgrade |
Cash & Short-Term Investments | 4,062 | 3,976 | 1,633 | 1,215 | 1,467 | 1,403 | Upgrade |
Cash Growth | 104.15% | 143.50% | 34.35% | -17.15% | 4.58% | -7.54% | Upgrade |
Accounts Receivable | 697 | 609.1 | 771.5 | 643 | 582.2 | 514.6 | Upgrade |
Other Receivables | 205.6 | 118.3 | 56.6 | 56.1 | 82.7 | 88.2 | Upgrade |
Total Trade Receivables | 902.6 | 727.4 | 828.1 | 699.1 | 664.9 | 602.8 | Upgrade |
Inventory | 1,142 | 1,087 | 903.5 | 875.5 | 726.7 | 802.3 | Upgrade |
Other Current Assets | 470.7 | 495.4 | 353.7 | 305.9 | 322.3 | 283.3 | Upgrade |
Total Current Assets | 6,577 | 6,285 | 4,036 | 3,096 | 3,181 | 3,091 | Upgrade |
Net Property, Plant & Equipment | 1,826 | 1,784 | 1,675 | 1,725 | 1,639 | 1,489 | Upgrade |
Other Intangible Assets | 1,173 | 1,177 | 399.4 | 285.2 | 323.6 | 331.4 | Upgrade |
Goodwill | 1,777 | 1,777 | 1,145 | 1,164 | 1,168 | 1,173 | Upgrade |
Long-Term Investments | 298.5 | 307.9 | 583.9 | 1,239 | 1,834 | 801.6 | Upgrade |
Other Long-Term Assets | 1,838 | 1,725 | 1,524 | 783.1 | 357.5 | 350.5 | Upgrade |
Total Assets | 13,489 | 13,055 | 9,363 | 8,293 | 8,503 | 7,237 | Upgrade |
Accounts Payable | 162.1 | 197.4 | 186.6 | 201.9 | 204.5 | 196.5 | Upgrade |
Accrued Expenses | 1,214 | 1,282 | 856.4 | 795 | 802.3 | 670.2 | Upgrade |
Current Portion of Leases | 25.9 | 23.4 | 22.9 | 25.5 | 25.5 | 27.2 | Upgrade |
Other Current Liabilities | 2.3 | 2 | 129.5 | - | - | - | Upgrade |
Total Current Liabilities | 1,405 | 1,505 | 1,195 | 1,022 | 1,032 | 893.9 | Upgrade |
Long-Term Debt | 598 | 597.7 | 597 | 596.3 | 595.7 | 595 | Upgrade |
Long-Term Leases | 78.7 | 78.9 | 65.2 | 69.5 | 69.1 | 72.7 | Upgrade |
Other Long-Term Liabilities | 800.8 | 810.6 | 786.2 | 797.6 | 969.6 | 1,101 | Upgrade |
Total Long-Term Liabilities | 1,478 | 1,487 | 1,448 | 1,463 | 1,634 | 1,769 | Upgrade |
Total Liabilities | 2,882 | 2,992 | 2,644 | 2,486 | 2,667 | 2,663 | Upgrade |
Common Stock | 657.6 | 654.8 | 650.5 | 646.3 | 642 | 636.4 | Upgrade |
Treasury Stock | -6,456 | -6,192 | -5,025 | -4,144 | -2,417 | -1,904 | Upgrade |
Additional Paid-in Capital | 2,750 | 2,613 | 2,274 | 1,969 | 1,700 | 1,438 | Upgrade |
Accumulated Other Comprehensive Income | -264.1 | -244.5 | -242.8 | -254.9 | -157.7 | -161.1 | Upgrade |
Retained Earnings | 13,858 | 13,167 | 8,992 | 7,590 | 6,068 | 4,565 | Upgrade |
Total Common Shareholders' Equity | 10,545 | 9,998 | 6,650 | 5,807 | 5,836 | 4,574 | Upgrade |
Minority Interest | 61.2 | 64.5 | 69.4 | - | - | - | Upgrade |
Shareholders' Equity | 10,607 | 10,063 | 6,719 | 5,807 | 5,836 | 4,574 | Upgrade |
Total Liabilities & Equity | 13,489 | 13,055 | 9,363 | 8,293 | 8,503 | 7,237 | Upgrade |
Total Debt | 702.6 | 700 | 685.1 | 691.3 | 690.3 | 694.9 | Upgrade |
Net Cash (Debt) | 3,360 | 3,276 | 947.7 | 524 | 776.5 | 707.7 | Upgrade |
Net Cash Growth | 2.56% | 245.67% | 80.86% | -32.52% | 9.72% | -15.56% | Upgrade |
Net Cash Per Share | 5.68 | 5.47 | 1.55 | 0.84 | 1.23 | 1.12 | Upgrade |
Book Value | 10,545 | 9,998 | 6,650 | 5,807 | 5,836 | 4,574 | Upgrade |
Book Value Per Share | 17.84 | 16.68 | 10.91 | 9.30 | 9.25 | 7.24 | Upgrade |
Tangible Book Value | 7,596 | 7,045 | 5,106 | 4,357 | 4,344 | 3,070 | Upgrade |
Tangible Book Value Per Share | 12.85 | 11.76 | 8.38 | 6.98 | 6.88 | 4.86 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.